Eternity Healthcare Inc (ETAH) financial statements (2022 and earlier)
Company profile
| Business Address |
C/O TEAM YOUN BIO MEDICINE INTL CORP LTD 18 CARNARVON RD TSIM SHA TSUII, 00000 |
| State of Incorp. | NV |
| Fiscal Year End | April 30 |
| SIC | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 7/31/2018 Q1 | 4/30/2018 Q4 | 1/31/2018 Q3 | 10/31/2017 Q2 | 7/31/2017 Q1 | 4/30/2017 Q4 | 1/31/2017 Q3 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 10 | 22 | 13 | 103 | 148 | 184 | |||
| Cash and cash equivalents | 10 | 22 | 13 | 103 | 148 | 184 | |||
| Inventory, net of allowances, customer advances and progress billings | 30 | 30 | |||||||
| Inventory | 30 | 30 | |||||||
| Prepaid expense | 173 | 4 | 24 | 300 | |||||
| Deferred costs | 37 | 37 | 37 | ||||||
| Other current assets | 116 | 18 | |||||||
| Other undisclosed current assets | 96 | 1 | 1 | ||||||
| Total current assets: | 163 | 77 | 320 | 108 | 203 | 515 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 2,224 | 1,538 | |||||||
| Deferred costs | 303 | 313 | 322 | ||||||
| Other undisclosed noncurrent assets | 29 | 31 | |||||||
| Total noncurrent assets: | 2,557 | 1,882 | 322 | ||||||
| Other undisclosed assets | 1 | ||||||||
| TOTAL ASSETS: | 2,720 | 1,959 | 642 | 108 | 204 | 515 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 23 | 13 | 363 | 17 | 139 | 129 | 139 | ||
| Interest and dividends payable | 23 | 13 | |||||||
| Other undisclosed accounts payable and accrued liabilities | 363 | 17 | 139 | 129 | 139 | ||||
| Due to related parties | 243 | 192 | 114 | 843 | 941 | 852 | 885 | ||
| Other liabilities | 1,781 | 1,183 | |||||||
| Total current liabilities: | 2,047 | 1,388 | 476 | 859 | 1,080 | 980 | 1,024 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 455 | 490 | |||||||
| Long-term debt, excluding current maturities | 455 | 490 | |||||||
| Other undisclosed noncurrent liabilities | (92) | (436) | |||||||
| Total noncurrent liabilities: | 363 | 54 | |||||||
| Other undisclosed liabilities | 455 | 490 | |||||||
| Total liabilities: | 2,865 | 1,931 | 476 | 859 | 1,080 | 980 | 1,024 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent, including: | (145) | 28 | 165 | (859) | (972) | (776) | (508) | ||
| Common stock | 171 | 171 | 171 | 71 | 71 | ||||
| Additional paid in capital | 3,020 | 3,020 | 3,020 | 1,947 | 1,947 | 1,947 | 1,882 | ||
| Accumulated other comprehensive income (loss) | 7 | (1) | (1) | (36) | 53 | 11 | |||
| Accumulated deficit | (3,343) | (3,162) | (3,024) | (2,877) | (2,954) | (2,847) | (2,470) | ||
| Other undisclosed stockholders' equity attributable to parent | 71 | 69 | |||||||
| Total stockholders' equity: | (145) | 28 | 165 | (859) | (972) | (776) | (508) | ||
| TOTAL LIABILITIES AND EQUITY: | 2,720 | 1,959 | 642 | 108 | 204 | 515 | |||
Income statement (P&L) ($ in thousands)
| 7/31/2018 Q1 | 4/30/2018 Q4 | 1/31/2018 Q3 | 10/31/2017 Q2 | 7/31/2017 Q1 | 4/30/2017 Q4 | 1/31/2017 Q3 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues (Financial Services Revenue) | 32 | |||||||
| Cost of revenue (Cost of Goods and Services Sold) | (55) | |||||||
| Gross profit: | 32 | (55) | ||||||
| Operating expenses | (183) | (125) | (140) | (21) | (99) | (368) | (135) | |
| Other undisclosed operating loss | (32) | |||||||
| Operating loss: | (183) | (125) | (140) | (21) | (154) | (368) | (135) | |
| Nonoperating income (expense) | 98 | (9) | (8) | (4) | ||||
| Other nonoperating expense | (8) | (4) | ||||||
| Interest and debt expense | (9) | (12) | (7) | (9) | (9) | (8) | (4) | |
| Income (loss) from continuing operations before equity method investments, income taxes: | (191) | (138) | (147) | 68 | (171) | (384) | (144) | |
| Other undisclosed income from continuing operations before income taxes | 11 | |||||||
| Net income (loss): | (181) | (138) | (147) | 68 | (171) | (384) | (144) | |
| Other undisclosed net income attributable to parent | 9 | 64 | 8 | 4 | ||||
| Net income (loss) available to common stockholders, diluted: | (181) | (138) | (147) | 77 | (107) | (377) | (140) | |
Comprehensive Income ($ in thousands)
| 7/31/2018 Q1 | 4/30/2018 Q4 | 1/31/2018 Q3 | 10/31/2017 Q2 | 7/31/2017 Q1 | 4/30/2017 Q4 | 1/31/2017 Q3 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (181) | (138) | (147) | 68 | (171) | (384) | (144) | |
| Other undisclosed comprehensive income (loss) | 49 | (19) | ||||||
| Comprehensive income (loss): | (181) | (138) | (147) | 68 | (171) | (335) | (163) | |
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 8 | (2) | 1 | 45 | (24) | |||
| Comprehensive income (loss), net of tax, attributable to parent: | (173) | (140) | (146) | 113 | (196) | (335) | (163) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.